Определение триметазидина в плазме крови методои ВЭЖХ со спектрофотометрическим детектированием [PDF]
ПЛАЗМАТРИМЕТАЗИДИНХРОМАТОГРАФИЯ ...
Жебентяев, А. И. +6 more
core
Background: Ischemic heart disease is the leading cause of heart failure. This study was conducted to see the effect of Trimetazidine on left ventricular function in heart failure secondary to ischemic heart disease.
Shimal Khan +4 more
doaj
The subject of study. AC-mode of chemotherapy-induced cardiotoxicity, and rationality of trimetazidine prescription. Purpose of the study – research the nuclear apparatus state of rats cardiomyocytes on chronic in vivo model of cancer therapy-driven ...
Ашот Арманович Авагимян
doaj
Neuropharmacological targets for drug action in vestibular sensory pathways [PDF]
The use of pharmacological agents is often the preferred approach to the management of vestibular dysfunction. In the vestibular sensory pathways, the sensory neuroepithelia are thought to be influenced by a diverse number of neuroactive substances that ...
Jones, Timothy A, Lee, Choongheon
core +3 more sources
Abstract No. 549 Trimetazidine in the prevention of contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography: a systematic review and meta-analysis [PDF]
Ashkan Heshmatzadeh Behzadi +2 more
openalex +1 more source
The effects of trimetazidine on lipopolysaccharide-induced oxidative stress in mice [PDF]
The effects of trimetazidine, a novel anti-ischemic agent, on the development of oxidative stress induced in mice with lipopolysaccharide endotoxin were investigated.
Abdel-Salam, Omar M.E. +2 more
core +1 more source
Trimetazidine Modulates Mitochondrial Redox Status and Disrupted Glutamate Homeostasis in a Rat Model of Epilepsy [PDF]
Muhammad Y. Al‐Shorbagy +2 more
openalex +1 more source
HOLTER ECG MONITORING AND TREATMENT EFFECTIVENESS CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION
In total, 316 patients after Q wave myocardial infarction (Q-MI) were randomised into 3 groups. For 6 months after discharge, the control group (n=103) received standard therapy (aspirin, enalapril, metoprolol, simvastatin). Group 1 (n=107) also received
U. A. Islamova +4 more
doaj
Clinical effectiveness of trimetazidine as a leading cardiovascular drug with metabolic action
Trimetazidine is proved to be a highly effective metabolic agent, compared to other drugs with the same action. Trimetazidine shifts cardiac energy metabolism from fatty acid oxidation towards glucose oxidation by inhibiting mitochondrial long-chain 3 ...
A. Yu. Gasparyan +2 more
doaj

